Skip to main content
logo
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.94
+0.45 (1.58%)
At close: Feb 27, 2026, 4:00 PM EST
29.00
+0.06 (0.21%)
After-hours: Feb 27, 2026, 7:42 PM EST

Roivant Sciences Revenue

Roivant Sciences had revenue of $2.00M in the quarter ending December 31, 2025, a decrease of -77.83%. This brings the company's revenue in the last twelve months to $13.31M, down -56.36% year-over-year. In the fiscal year ending March 31, 2025, Roivant Sciences had annual revenue of $29.05M, down -11.19%.

Revenue (ttm)
$13.31M
Revenue Growth
-56.36%
P/S Ratio
1,556.15
Revenue / Employee
$17,747
Employees
750
Market Cap
20.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M1.18M3.75%
Mar 31, 202331.53M-23.76M-42.97%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 202067.69M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte5.14B
Genmab3.72B
BioNTech SE3.70B
Royalty Pharma2.38B
Moderna1.94B
Ionis Pharmaceuticals944.00M
Ascendis Pharma845.52M
Insmed606.42M
Revenue Rankings

ROIV News

More News